melanotan 2 clinical trials II - an overview Melanotan II (MT-2) 10mg Cyclic

Sarah Mess has either authored or reviewed and approved this content

For further details, see Jones et al., Nature, 321 : 522-525 (1986)

VanElzakker [email protected] This article was submitted to Pediatric Neurology, a section of the journal Frontiers in Neurology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

The Importance of Working with a Clinician Given the complexities and potential risks associated with carnitine supplementation, especially in individuals with serious mental health conditions, it is crucial to work with a clinician